VAGIFEM®—The only prescription vaginal estrogen tablet that is designed to relieve the discomfort associated with menopausal atrophic vaginitis.
Glossary
Atrophic vaginitis
Thinning of vaginal tissues with irritation, pain and inflammation; due to loss of estrogen at menopause.
Endometrial cancer
Cancer of the lining of the uterus.
Estradiol
A potent type of estrogen produced by the body; the predominant form of estrogen before menopause. The active ingredient in VAGIFEM® tablets.
Estrogen
Hormone secreted by the ovaries that influence a woman's sexual development and menstrual cycle.
Estrogen therapy (ET)
Treatment to provide the estrogen no longer made by the body after menopause.
Estrone
A weak type of estrogen produced in small amounts in fat tissue; the predominant form of estrogen after menopause.
Hormones
Chemical substances made by the body that control various body functions.
Hormone therapy (HT)
Treatment to provide women with the hormones no longer made by the body after menopause.
Hot flashes or hot flushes
"Heat waves" that flush the upper body and face; caused by declining levels of estrogen during perimenopause.
Local estrogen therapy (LET)
Estrogen used vaginally for the treatment of atrophic vaginitis. VAGIFEM® tablets are a form of local estrogen therapy.
Menopause
The cessation of menstrual periods; occurs at the time of a woman’s final menstrual period, but is determined following 12 months without a period. Average age among women is 51 years.
Menstrual
Relating to menstruation, the monthly shedding of the lining of the uterus in women of childbearing age.
